Alig, A.H.S.; Heinemann, V.; Geissler, M.; Fischer von Weikersthal, L.; Decker, T.; Heinrich, K.; Held, S.; Weiss, L.; Fischer, L.E.; Moosmann, N.;
et al. Exact Primary Tumor Location in mCRC: Prognostic Value and Predictive Impact on Anti-EGFR mAb Efficacy. Cancers 2022, 14, 526.
https://doi.org/10.3390/cancers14030526
AMA Style
Alig AHS, Heinemann V, Geissler M, Fischer von Weikersthal L, Decker T, Heinrich K, Held S, Weiss L, Fischer LE, Moosmann N,
et al. Exact Primary Tumor Location in mCRC: Prognostic Value and Predictive Impact on Anti-EGFR mAb Efficacy. Cancers. 2022; 14(3):526.
https://doi.org/10.3390/cancers14030526
Chicago/Turabian Style
Alig, Annabel H. S., Volker Heinemann, Michael Geissler, Ludwig Fischer von Weikersthal, Thomas Decker, Kathrin Heinrich, Swantje Held, Lena Weiss, Laura E. Fischer, Nicolas Moosmann,
and et al. 2022. "Exact Primary Tumor Location in mCRC: Prognostic Value and Predictive Impact on Anti-EGFR mAb Efficacy" Cancers 14, no. 3: 526.
https://doi.org/10.3390/cancers14030526
APA Style
Alig, A. H. S., Heinemann, V., Geissler, M., Fischer von Weikersthal, L., Decker, T., Heinrich, K., Held, S., Weiss, L., Fischer, L. E., Moosmann, N., Stahler, A., Jelas, I., Kurreck, A., von Einem, J. C., Reinacher-Schick, A. C., Tannapfel, A., Giessen-Jung, C., Stintzing, S., & Modest, D. P.
(2022). Exact Primary Tumor Location in mCRC: Prognostic Value and Predictive Impact on Anti-EGFR mAb Efficacy. Cancers, 14(3), 526.
https://doi.org/10.3390/cancers14030526
